Paradigm Initiates Coverage On Trulieve With
Paradigm Initiates Coverage On Trulieve With $59 Price Target
Earlier this month, Paradigm Capital initiated coverage on Trulieve Cannabis Corp (CSE: TRUL) with a C$59 12-month price target and a Speculative buy rating.